Topic: FDA warning letter
The FDA bit into homeopathic pharmaceutical manufacturer Homeolab USA over belladonna-treated teething products that CVS took off the shelf last year.
A Canadian company that sells topical vitamin C skin treatments is in trouble with the FDA, which says it needs is a dose of cGMP practices.
GSK will close its Shanghai neuroscience R&D hub, Pfizer and Astellas stopped Xtandi's breast cancer study and more.
Dr. Reddy's CEO GV Prasad says the generic drugmaker’s top priority is to do what is needed to get its manufacturing up to FDA expectations.
The FDA has slapped an Italian sterile manufacturer with a warning letter pointing to the contamination hazards tied to its highly manual processes.
The FDA has warned the maker of an OTC oral rinse product to stop manufacturing it on the same equipment it uses to produce a car polish.
A whistleblower suit against Gilead is revived, Biocon and Mylan's Herceptin biosim is delayed, and AZ is upping production to meet demands in China.
The FDA has issued a warning letter to India's Vista Pharmaceuticals after it found it using corroded equipment.
An FDA warning letter has been issued to a CMO that made belladonna-treated teething products that the agency warned may cause seizures in infants.
China’s FDA joined ICH, Takeda completed new solid dosage plant, the FDA bans imports of Ipca drugs.